OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 16
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 16
Showing 16 citing articles:
Leveraging artificial intelligence in vaccine development: A narrative review
David B. Olawade, Jennifer Teke, Oluwaseun Fapohunda, et al.
Journal of Microbiological Methods (2024) Vol. 224, pp. 106998-106998
Open Access | Times Cited: 17
David B. Olawade, Jennifer Teke, Oluwaseun Fapohunda, et al.
Journal of Microbiological Methods (2024) Vol. 224, pp. 106998-106998
Open Access | Times Cited: 17
Short Peptides as Powerful Arsenal for Smart Fighting Cancer
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
Alginate/magnetic hydroxyapatite bio-nanocomposite hydrogel bead as a pH-responsive oral drug carrier for potential colon cancer therapy
Rauf Foroutan, Ali Mohammadzadeh, Siamak Javanbakht, et al.
Results in Chemistry (2025), pp. 102177-102177
Open Access
Rauf Foroutan, Ali Mohammadzadeh, Siamak Javanbakht, et al.
Results in Chemistry (2025), pp. 102177-102177
Open Access
Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions
S. Chattopadhyay, Arunava Goswami, Moumita Sil
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
S. Chattopadhyay, Arunava Goswami, Moumita Sil
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review
Mohanna Khandan, Mohammad Amin Khazeei Tabari, Seyed Mostafa Rahimi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mohanna Khandan, Mohammad Amin Khazeei Tabari, Seyed Mostafa Rahimi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Prostate Cancer Vaccines: Progress, Challenges, and Future Directions
Stefanus Vicky Bernhard Elisa Runtunuwu, Trina Ekawati Tallei, Grace L. A. Turalaki
Heca Journal of Applied Sciences (2025) Vol. 3, Iss. 1, pp. 30-55
Closed Access
Stefanus Vicky Bernhard Elisa Runtunuwu, Trina Ekawati Tallei, Grace L. A. Turalaki
Heca Journal of Applied Sciences (2025) Vol. 3, Iss. 1, pp. 30-55
Closed Access
Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy
Theivendren Panneerselvam, Selvaraj Kunjiappan, Parasuraman Pavadai, et al.
ACS Measurement Science Au (2024) Vol. 5, Iss. 1, pp. 31-55
Open Access | Times Cited: 3
Theivendren Panneerselvam, Selvaraj Kunjiappan, Parasuraman Pavadai, et al.
ACS Measurement Science Au (2024) Vol. 5, Iss. 1, pp. 31-55
Open Access | Times Cited: 3
Biocompatability chitosan /Aloe barbadensis miller loaded moxifloxacin composite film: A multifunctional bio-platform for the treatment of breast cancer
Gowri Rengasamy, Sundrarajan Mahalingam, Thamayanthi Udaiyar, et al.
Journal of Molecular Structure (2024) Vol. 1315, pp. 138618-138618
Closed Access | Times Cited: 2
Gowri Rengasamy, Sundrarajan Mahalingam, Thamayanthi Udaiyar, et al.
Journal of Molecular Structure (2024) Vol. 1315, pp. 138618-138618
Closed Access | Times Cited: 2
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Recent Progress in Cancer Vaccines and Nanovaccines
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 2
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 2
Investigation of Reasons for the Reluctance to get Vaccinated with COVID-19 in the General Population in the South of Kerman Province (A Cross-sectional Study)
Amin Saeedi, Rasoul Raesi, Salman Daneshi, et al.
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Amin Saeedi, Rasoul Raesi, Salman Daneshi, et al.
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model
Sara Mathlouthi, Łukasz Kuryk, Marta Prygiel, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 777-793
Open Access | Times Cited: 1
Sara Mathlouthi, Łukasz Kuryk, Marta Prygiel, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 777-793
Open Access | Times Cited: 1
Synthesis, Anticancer Evaluation and Molecular Docking Studies of 1-(2-Fluorobenzyl)piperazine Triazoles: A Novel Breast Cancer Cell Inhibitors
L. Beliyaiah, Javarappa Rangaswamy, Abhirami Dilkalal, et al.
Asian Journal of Chemistry (2024) Vol. 36, Iss. 4, pp. 948-954
Open Access
L. Beliyaiah, Javarappa Rangaswamy, Abhirami Dilkalal, et al.
Asian Journal of Chemistry (2024) Vol. 36, Iss. 4, pp. 948-954
Open Access
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium
Eric S. Schafer, Teresa Rushing, Kristine R. Crews, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 11, pp. 1721-1729
Closed Access
Eric S. Schafer, Teresa Rushing, Kristine R. Crews, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 11, pp. 1721-1729
Closed Access
PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer
Swastika Maitra, Nobendu Mukerjee, Dattatreya Mukherjee, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 4
Open Access
Swastika Maitra, Nobendu Mukerjee, Dattatreya Mukherjee, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 4
Open Access
Current Advances in Immunotherapy for Cancer
I Desai, Saee Thakur, Pradeep Pagariya
Oral Oncology Reports (2024), pp. 100652-100652
Open Access
I Desai, Saee Thakur, Pradeep Pagariya
Oral Oncology Reports (2024), pp. 100652-100652
Open Access
Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles
Carolyne B. Braga, Gabriel Perli, Rafael Hinojal Fonseca, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 11, pp. 5577-5597
Closed Access
Carolyne B. Braga, Gabriel Perli, Rafael Hinojal Fonseca, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 11, pp. 5577-5597
Closed Access
